Amplify Surgical

Executive Summary

Amplify Surgical is a privately held medical device company based in Irvine, California, focused on advancing minimally invasive spinal surgery through its proprietary dualPortal® approach. Founded in 2014, the company has developed a biportal endoscopic system designed to improve visualization, access, and surgical outcomes while reducing tissue trauma. By combining didactic learning and hands-on cadaver workshops, Amplify Surgical educates surgeons on the dualPortal technique, aiming to drive adoption and establish a new standard of care in spine surgery. The company's platform addresses key pain points in traditional open and MIS procedures, offering potential benefits in recovery time, complication rates, and cost-effectiveness. While currently in a growth phase with limited public financial data, Amplify Surgical's innovative approach positions it well within the expanding minimally invasive spine market, which is projected to grow significantly over the next decade. The company's success hinges on gaining regulatory clearances, publishing clinical evidence, and expanding its commercial footprint.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) Clearance for Expanded Indications75% success
• Q4 2026First Commercial Sales and Revenue Milestone60% success
• Q2 2026Presentation of Prospective Clinical Study Results at Major Spine Conference70% success